HRL vs INMB · P/E 29, rev $8.96B vs rev $50.0K
Hormel Foods Corporation (HRL) versus INmune Bio Inc (INMB) — a side-by-side from cached financials, not a winner call.
Hormel Foods Corporation (HRL) is a packaged foods company listed on NYSE.
INmune Bio Inc (INMB) is a biotechnology company listed on US.
Latest reported HRL revenue for 2026-07-26 was $8.96B. Net income was $398.8M. Revenue was up 49.4% from 2026-04-26 to 2026-07-26. HRL currently screens at market cap $13.39B and trailing P/E 28.6.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
HRL currently screens at market cap $13.39B and trailing P/E 28.6. INMB currently screens at market cap $33.5M.
Not investment advice. Open the HRL and INMB stock pages for the full models.
Not investment advice.